RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases
- PMID: 12641088
RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases
Comment on
-
RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.Nat Genet. 2002 Dec;32(4):581-3. doi: 10.1038/ng1021. Epub 2002 Nov 4. Nat Genet. 2002. PMID: 12415269
Publication types
LinkOut - more resources
Full Text Sources
Molecular Biology Databases